Abeona Therapeutics (ABEO) Stock Price, Quote, News & History

Comments

Abeona Therapeutics Inc (ABEO) Stock Price, Quote, News & History

ABEONASDAQ

Trade with Public

$4.76

-0.20-3.94%

At close: Mar 13, 5:00 PM EST

$4.76

N/A

After Hours: 7:32 PM EST

Earnings: Q4 2025 Earnings in 3 days from now on Tue Mar 17th, before the market open

Conference Call: Conference call scheduled in 3 days at 8:30 AM

Click to view the webcast

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$4.92

Close

$4.76

Volume / Avg.

1.06M / 1.14M

Day Range

$4.73 - $5.02

52 Wk Range

3.93 - 7.54

Market Cap

$257.95M

P/E Ratio

4.10

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

25.68%

Days to Cover

15.22

Recent Abeona Therapeutics Inc News

PRO
HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20 price target.

Benzinga Newsdesk

PRO
Abeona Therapeutics Announces First Commercial Patient Treatment With FDA-Approved ZEVASKYN Gene Therapy For RDEB Wounds At Lucile Packard Children's Hospital Stanford

Benzinga Newsdesk

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga Insights

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-74.93M

Investing Cash Flow (TTM)

114.35M

Financing Cash Flow (TTM)

27.74M

Free Cash Flow (TTM)

-82.36M

Capital Expenditure (TTM)

-7.43M

Net Change in Cash (TTM)

67.16M

Analyst Trends and Forecast

1

Oct 25

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$74.94M

PE Ratio (TTM)

4.10

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

761.90

PB Ratio (TTM)

1.57

Earnings Yield % (TTM)

24.42%

Earnings Yield % (FWD)

-5.25%

EV / EBITDA (TTM)

0.95

Price / EBITDA (TTM)

3.39

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.16

Company Debt

Total Debt

$19.75M

LT Debt

$10.86M

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-

Total Cash

$82.88M

Debt to Equity

0.14

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

-

Key Statistics

Open

$4.92

Close

$4.76

Volume / Avg.

1.06M / 1.14M

Day Range

$4.73 - $5.02

52 Wk Range

3.93 - 7.54

Market Cap

$257.95M

P/E Ratio

4.10

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

25.68%

Days to Cover

15.22

About

Sector

Health Care

Industry

Biotechnology

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engi...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Abeona Therapeutics (ABEO) stock?

A

You can purchase shares of Abeona Therapeutics (NASDAQ:ABEO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Abeona Therapeutics (ABEO) competitors?

A

Other companies in Abeona Therapeutics’s space includes: Atrium Therapeutics Inc (NASDAQ:RNA), Voyager Therapeutics Inc (NASDAQ:VYGR), Burning Rock Biotech Ltd (NASDAQ:BNR), Palisade Bio Inc (NASDAQ:PALI) and AC Immune SA (NASDAQ:ACIU).

Q

What is the forecast, or price target, for Abeona Therapeutics (ABEO) stock?

A

Abeona Therapeutics has a consensus price target of $18.43.

Q

What is the current price for Abeona Therapeutics (ABEO)?

A

The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $4.76 last updated March 13, 2026 at 7:32 PM EDT.

Q

Does Abeona Therapeutics (ABEO) pay a dividend?

A

There are no upcoming dividends for Abeona Therapeutics.

Q

When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?

A

Abeona Therapeutics does not have any upcoming earnings scheduled.

Q

Is Abeona Therapeutics (ABEO) going to split?

A

There is no upcoming split for Abeona Therapeutics.

Q

What sector and industry does Abeona Therapeutics (ABEO) operate in?

A

Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Atrium Therapeutics Inc

NASDAQ:RNA

$13.75

%

Voyager Therapeutics Inc

NASDAQ:VYGR

$4.81

7.97%

Burning Rock Biotech Ltd

Fennec Pharmaceuticals Inc

Key Statistics

Open

$4.92

Close

$4.76

Volume / Avg.

1.06M / 1.14M

Day Range

$4.73 - $5.02

52 Wk Range

3.93 - 7.54

Market Cap

$257.95M

P/E Ratio

4.10

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

25.68%

Days to Cover

15.22

Recent Abeona Therapeutics Inc News

PRO
HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20 price target.

Benzinga Newsdesk

PRO
Abeona Therapeutics Announces First Commercial Patient Treatment With FDA-Approved ZEVASKYN Gene Therapy For RDEB Wounds At Lucile Packard Children's Hospital Stanford

Benzinga Newsdesk

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga Insights

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-74.93M

Investing Cash Flow (TTM)

114.35M

Financing Cash Flow (TTM)

27.74M

Free Cash Flow (TTM)

-82.36M

Capital Expenditure (TTM)

-7.43M

Net Change in Cash (TTM)

67.16M

Analyst Trends and Forecast

1

Oct 25

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$74.94M

PE Ratio (TTM)

4.10

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

761.90

PB Ratio (TTM)

1.57

Earnings Yield % (TTM)

24.42%

Earnings Yield % (FWD)

-5.25%

EV / EBITDA (TTM)

0.95

Price / EBITDA (TTM)

3.39

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.16

Company Debt

Total Debt

$19.75M

LT Debt

$10.86M

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-

Total Cash

$82.88M

Debt to Equity

0.14

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

-

Key Statistics

Open

$4.92

Close

$4.76

Volume / Avg.

1.06M / 1.14M

Day Range

$4.73 - $5.02

52 Wk Range

3.93 - 7.54

Market Cap

$257.95M

P/E Ratio

4.10

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

25.68%

Days to Cover

15.22

About

Sector

Health Care

Industry

Biotechnology

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engi...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry